FYLREVY

This brand name is authorized in Estonia.

Active ingredients

The drug FYLREVY contains one active pharmaceutical ingredient (API):

1	Estetrol UNII KC3GI9UM9V - ESTETROL MONOHYDRATE
	The active ingredient, synthetic estetrol, is chemically and biologically identical to endogenous estetrol that is produced during pregnancy by the human foetal liver. Estetrol substitutes for the loss of oestrogen production in menopausal women, and alleviates menopausal symptoms, including vasomotor symptoms (VMS).

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
FYLREVY Film-coated tablet	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
G03CA10		G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03C Estrogens → G03CA Natural and semisynthetic estrogens, plain
Discover more medicines within G03CA10

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	3148635, 3148646